FORBES-TATE

Lobbying for JOHNSON & JOHNSON · Multinational pharmaceutical, biotechnology, and medical technologies corporation.

Filing Registration

3rd Quarter (July 1 - Sep 30) 2026 · District of Columbia · posted Aug 14, 2026

Lobbying activity 2

Health Issues

Issues related to the 340B Drug Pricing Program.

Medicare/Medicaid

Issues related to the 340B Drug Pricing Program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.